Resproly Australia

Resproly is an Australian biotechnology company that specializes in the development and optimization of inhaled and nasal drug products. Based in Sydney, the company provides end-to-end services including formulation development, device integration, and advanced analytical testing for respiratory therapies. Resproly's expertise spans various delivery platforms such as dry powder inhalers (DPIs), pressurized metered-dose inhalers (pMDIs), and nebulizers. The firm supports the development of both small molecules and biologics, utilizing specialized technologies like particle engineering and spray drying. By offering tailored R&D solutions, Resproly helps pharmaceutical partners navigate the complexities of pulmonary drug delivery from concept to clinical trials.